|
David Dvorak, 44, was appointed President and Chief Executive Officer and a member of the Board of Directors on May 1, 2007.
Mr. Dvorak joined Zimmer in December 2001 shortly following the spin-off from Bristol-Myers Squibb. Prior to joining Zimmer, he was Senior Vice President, General Counsel and Secretary for STERIS Corporation, an Ohio-based leader in medical products sterilization and contamination prevention products and services. He practiced law with two major Ohio firms with a focus on corporate law, securities and mergers and acquisitions. Mr. Dvorak received his Bachelor of Science in Business Administration (Finance) from Miami University (OH) and his J.D., magna cum laude, from Case Western Reserve University School of Law, where he was awarded The Order of the Coif. | 